retatrutide phase 3 trials just delivered the most powerful weight loss data ever recorded in a obesity trial. At 104 weeks, participants on the 12 mg dose lost an average of 85 pounds Today, we shared new data

this choice may have helped avoid patients unable to access the drug due to insurance issues after initial order, but did nothing to address the question of people getting access through alternate sources external to our system

has taken or is taking a GLP-1 agonist

Probiotics Given the gut-thyroid connection discussed earlier, probiotic supplementation makes physiological sense for Hashimoto's patients on GLP-1 therapy

All Felix shipments arrive in a nondescript blister package so you can have your treatment shipped wherever makes sense for you as long as there is someone there to sign for it

The challenge is the lack of robust clinical data backing these alternatives

Because it focuses on insulin sensitivity and liver glucose production, it provides a steady foundation for metabolic stability